GEHC Stock Analysis: Buy, Sell, or Hold?
GEHC - GE HealthCare Technologies Inc. Common Stock
$68.02
-1.92 (-2.75%)
▼
5d:
+12.28%
30d:
+4.87%
90d:
+11.8%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 7.7/10
Get Alerted When GEHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GEHC shows positive signals but monitor for confirmation. Market pricing in 2.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: GEHC shows positive signals but monitor for confirmation. Market pricing in 2.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$103.79
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$64.45
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GEHC is currently trading at $68.02, which is considered extended relative to its 30-day fair value range of $61.85 to $66.85. The stock's valuation (Forward PE: 12.6) is in line with its historical norms (13.7). Remarkably, the market is currently pricing in an annual earnings decline of 2.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, GEHC is in a strong downtrend. Immediate support is located at $60.20, while resistance sits at $72.04.
Market Sentiment: GEHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $81.72 (+20.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GEHC is in a strong downtrend. Immediate support is located at $60.20, while resistance sits at $72.04.
Market Sentiment: GEHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $81.72 (+20.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$61.85 -
$66.85
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.1% below Wall St target ($81.72)
Trading Range Analysis
30-Day Trading Range
$61.85 -
$66.85
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$60.20
Resistance Level
$72.04
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.58
Wall Street Target
$81.72
(+20.1%)
Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
-30.9%
Profit Margin
9.1%
Valuation Discount vs History
-2.7% cheaper
PE vs Historical
12.6 vs 13.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.7%
(market-implied from PE analysis)
1-Year Target
$66.18
(-3%)
2-Year Target
$64.40
(-5%)
3-Year Target
$62.66
(-8%)
3-Yr Target (if PE normalizes)
(PE: 13→14)
$68.24
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 10.0%)
$149.14
(+119%)
Base:
(SPY PE: 12.6, Growth: 10.0%)
$90.50
(+33%)
Bear:
(PE: 10.7, Growth: 10.0%)
$76.93
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 16.57 | Current EPS (TTM): $4.22
Bull Case
$98.57
(+45%)
Analyst growth 28.1%, PE expands to 18.2
Base Case
$89.61
(+32%)
Market implied 28.1%, PE stable at 16.6
Bear Case
$47.56
(-30%)
Severe decline -20.0%, PE contracts to 14.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.6 to 13.7
Stabilization Target:
$74.08
(+8.9%)
PE Expansion Potential:
+8.9%
Share & Embed Analysis
Last updated: August 02, 2026 10:48 AM ET
Data refreshes hourly during market hours. Next update: 11:48 AM
Data refreshes hourly during market hours. Next update: 11:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GEHC showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Terri A. Sewell
SELL
2026-03-25
Warren Davidson
SELL
2026-03-23
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 52 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 60 HOLD |
Advanced GEHC Option Strategies
Professional options setups generated by AI based on today's GEHC price and gamma walls.
